- Home
- FCAP vs SGMO Comparison
FCAP vs SGMO Comparison
Compare FCAP & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCAP | SGMO |
|---|---|---|
| Founded | 1891 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.0M | 141.2M |
| IPO Year | 1998 | 2000 |
Fundamental Metrics
Financial Performance| Metric | FCAP | SGMO |
|---|---|---|
| Price | $49.37 | $0.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 2.4K | ★ 4.4M |
| Earning Date | 04-24-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.56% | N/A |
| EPS Growth | N/A | ★ 66.89 |
| EPS | ★ 3.43 | N/A |
| Revenue | $7,059,000.00 | ★ $36,567,000.00 |
| Revenue This Year | N/A | $4.79 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $14.14 | ★ N/A |
| Revenue Growth | 0.71 | ★ 88.60 |
| 52 Week Low | $33.88 | $0.32 |
| 52 Week High | $71.00 | $0.84 |
Technical Indicators
Market Signals| Indicator | FCAP | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 46.52 | 36.64 |
| Support Level | $47.48 | N/A |
| Resistance Level | $54.40 | $0.55 |
| Average True Range (ATR) | 0.99 | 0.03 |
| MACD | 0.22 | -0.00 |
| Stochastic Oscillator | 66.51 | 4.91 |
Price Performance
Historical ComparisonAbout FCAP First Capital Inc.
First Capital Inc is the financial holding company of First Harrison Bank. Through its subsidiary, it operates as a federally-chartered savings bank that provides banking services to individuals and business customers across locations in America. The bank offers various loans which include residential loans, construction loans, commercial real estate loans and commercial business loans. It also provides consumer loans such as home equity and second mortgage loans, and automobile and truck loans.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.